Champions Oncology, Inc. (CSBR)

Champions Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 10, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Cap	89	99	66	66	104	144
Market Cap Growth	38.75%	49.41%	0.16%	-36.62%	-27.85%	46.50%
Enterprise Value	82.89	93.36	69.4	63.1	103.26	148.03
Last Close Price	6.44	7.15	4.85	4.86	7.68	10.73
PE Ratio	30.18	21.67	-8.98	-12.46	192.00	536.50
Forward PE	42.93	119.17	-	-	42.95	77.31
PEG Ratio	-	-	-	-	2.86	5.44
PS Ratio	1.58	1.73	1.31	1.22	2.11	3.51
PB Ratio	25.78	26.12	-34.65	14.20	11.42	19.38
P/TBV Ratio	6294.14	27.04	-34.53	14.20	11.96	21.05
P/FCF Ratio	12.06	14.08	-9.46	59.84	25.25	-29.01
P/OCF Ratio	11.37	13.34	-10.74	16.57	15.98	-85.62
EV/Sales Ratio	1.46	1.64	1.38	1.17	2.10	3.61
EV/EBITDA Ratio	18.18	15.07	-12.64	-20.96	46.22	95.50
EV/EBIT Ratio	27.54	20.50	-9.44	-12.00	170.11	404.45
EV/FCF Ratio	11.45	13.34	-9.95	57.36	25.11	-29.83
Debt / Equity Ratio	1.19	1.23	-3.20	1.59	0.92	1.18
Debt / EBITDA Ratio	1.26	0.99	-1.35	-2.86	4.24	6.19
Debt / FCF Ratio	0.79	0.87	-1.07	7.82	2.30	-1.93
Asset Turnover	2.04	1.95	1.66	1.55	1.56	1.70
Quick Ratio	0.87	0.88	0.56	0.83	1.06	1.04
Current Ratio	0.93	0.94	0.63	0.90	1.13	1.13
Return on Equity (ROE)	141.68%	495.02%	-534.80%	-77.70%	6.63%	5.78%
Return on Assets (ROA)	10.79%	15.57%	-24.34%	-15.28%	1.81%	1.25%
Return on Capital (ROIC)	12.41%	17.15%	-26.72%	-18.72%	2.28%	1.70%
Return on Capital Employed (ROCE)	42.31%	69.61%	-85.69%	-34.49%	3.54%	2.95%
Earnings Yield	3.38%	4.62%	-11.13%	-8.02%	0.52%	0.19%
FCF Yield	8.30%	7.10%	-10.58%	1.67%	3.96%	-3.45%
Buyback Yield / Dilution	0.00%	-0.32%	0.58%	-0.02%	-0.20%	-0.95%
Total Shareholder Return	-	-0.32%	0.58%	-0.02%	-0.20%	-0.95%

Updated Jul 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q